Search

Your search keyword '"Wharam MD"' showing total 1,535 results

Search Constraints

Start Over You searched for: "Wharam MD" Remove constraint "Wharam MD"
1,535 results on '"Wharam MD"'

Search Results

2. Late dental and bone alterations in patients after orbital rhabdomyosarcoma treatment.

4. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy.

6. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.

7. Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.

9. Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

10. Patterns of failure after involved field radiation therapy for pediatric and young adult Hodgkin lymphoma.

12. Management of pediatric spinal cord astrocytomas: outcomes with adjuvant radiation.

13. Radiotherapy for rhabdomyosarcoma: indications and outcome.

15. Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma.

16. Clinical results of a pilot study on stereovision-guided stereotactic radiotherapy and intensity modulated radiotherapy.

17. Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis.

18. Neuroimaging and neuropsychological follow-up study in a pediatric brain tumor patient treated with surgery and radiation.

19. Risk of second tumor in intracranial germinoma patients treated with radiation therapy: the Johns Hopkins experience.

20. Outcome analysis of childhood low-grade astrocytomas.

21. HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks.

23. Ewing sarcoma bone metastases: 'you see one, you've seen them all': (commentary on Furth et al., page 607).

24. POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.

25. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.

26. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.

27. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.

28. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.

29. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study.

30. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.

31. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.

32. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.

33. Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.

34. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.

35. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.

36. Second surgery for recurrent pilocytic astrocytoma in children.

37. Prognostic implications for gadolinium enhancement of the meninges in low-grade astrocytomas of childhood.

38. The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols.

39. A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities.

40. Pre-irradiation evaluation and management of brain metastases. American College of Radiology. ACR Appropriateness Criteria.

41. Multiple brain metastases. American College of Radiology. ACR Appropriateness Criteria.

42. Follow-up and retreatment of brain metastasis. American College of Radiology. ACR Appropriateness Criteria.

43. Solitary brain metastasis. American College of Radiology. ACR Appropriateness Criteria.

44. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma.

45. Tectal gliomas: natural history of an indolent lesion in pediatric patients.

46. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.

47. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group.

48. Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma?

49. Outcomes and failure patterns in childhood craniopharyngiomas.

50. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.

Catalog

Books, media, physical & digital resources